Search - tctmd.com

Displaying 1 - 20 of 210

Sort: Relevancy | Date

News Conference News VIVA 2025

ENGULF Novel PE Thrombectomy Device Minimizes Blood Loss

L.A. McKeown

November 07, 2025

Presentation TCT 2025

TCT 725: First in Man (FIM) Experience of the Vivasure PerQseal® ELITE System for Large Hole Venous Closure: ELITE Venous Study

Presenter: Antigone Kostea

October 27, 2025

Presentation TCT 2025

TCT 714: Final Results from the US Pivotal Study of the Vivasure PerQseal® System for Large Hole Closure: PATCH

Presenter: Zvonimir Krajcer

October 27, 2025

Presentation TCT 2025

TCT 715: First in Man (FIM) Experience of the Vivasure PerQseal® ELITE System for Large Hole Closure: ELITE and ELITE Venous Studies

Presenter: Lucas Uchoa de Assis

October 27, 2025

Presentation TCT 2025

The Vivasure PerQseal® System for Large Bore Closure: Results from the US Pivotal PATCH Study

Presenter: Zvonimir Krajcer

October 26, 2025

News Conference News EACTS 2025

SAVR Bests TAVI for 5-Year Survival in Combined RCT, Observational Data

Yael L. Maxwell

October 10, 2025

Presentation NY Valves 2025

First in Man (FIM) Experience of the Vivasure PerQseal® ELITE System for Large Bore Closure: ELITE and ELITE Venous Studies

Presenter: Nicolas M. Van Mieghem

June 27, 2025

Presentation NY Valves 2025

Hybrid Surgical Technique for Mitral Valve Replacement in Mitral Annular Calcifcation Utilizing a Modified Transcatheter Valve

Presenter: Alessandro Vivacqua

June 25, 2025

News Daily News

Top Endovascular News of 2024

L.A. McKeown

December 28, 2024

News Daily News

CV Health Starts to Decline Around Age 10

Todd Neale

December 23, 2024

News Conference News VIVA 2024

It’s Been 1 Year Since Medicare’s NCD for Carotid Stenting: What Now?

L.A. McKeown

November 14, 2024

News Conference News VIVA 2024

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

L.A. McKeown

November 11, 2024

News Conference News VIVA 2024

Advocates Urge Heat Maps and Grassroots Campaigns to Improve PAD Care

L.A. McKeown

November 07, 2024

News Conference News VIVA 2024

Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II

L.A. McKeown

November 06, 2024

News Conference News VIVA 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

L.A. McKeown

November 05, 2024

Presentation TCT 2024

First in Man (FIM) Experience of the Vivasure PerQseal® ELITE System for Large Hole Closure: The ELITE and ELITE Venous Studies

Presenter: Nicolas Van Mieghem

October 28, 2024

Presentation TCT 2024

Final Results of the PATCH Study of the Vivasure PerQseal® System for Large Hole Closure

Presenter: William Gray

October 28, 2024

Podcast TCTMD Talking Points

The VIVA Trial

May 15, 2024

Presentation THT Abstracts 2024

Early Feasibility Study of the Vivasure PerQsealÆ Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Presenter: Rajiv Tayal

March 04, 2024

Presentation THT 2024

Early Feasibility Study of the Vivasure PerQseal® Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Presenter: Rajiv Tayal

March 04, 2024

Advertisement

ENGULF Novel PE Thrombectomy Device Minimizes Blood Loss

TCT 725: First in Man (FIM) Experience of the Vivasure PerQseal® ELITE System for Large Hole Venous Closure: ELITE Venous Study

TCT 714: Final Results from the US Pivotal Study of the Vivasure PerQseal® System for Large Hole Closure: PATCH

TCT 715: First in Man (FIM) Experience of the Vivasure PerQseal® ELITE System for Large Hole Closure: ELITE and ELITE Venous Studies

The Vivasure PerQseal® System for Large Bore Closure: Results from the US Pivotal PATCH Study

SAVR Bests TAVI for 5-Year Survival in Combined RCT, Observational Data

First in Man (FIM) Experience of the Vivasure PerQseal® ELITE System for Large Bore Closure: ELITE and ELITE Venous Studies

Hybrid Surgical Technique for Mitral Valve Replacement in Mitral Annular Calcifcation Utilizing a Modified Transcatheter Valve

Top Endovascular News of 2024

CV Health Starts to Decline Around Age 10

It’s Been 1 Year Since Medicare’s NCD for Carotid Stenting: What Now?

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

Advocates Urge Heat Maps and Grassroots Campaigns to Improve PAD Care

Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

First in Man (FIM) Experience of the Vivasure PerQseal® ELITE System for Large Hole Closure: The ELITE and ELITE Venous Studies

Final Results of the PATCH Study of the Vivasure PerQseal® System for Large Hole Closure

The VIVA Trial

Early Feasibility Study of the Vivasure PerQsealÆ Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Early Feasibility Study of the Vivasure PerQseal® Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content